Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2->MET *** > Treatment > USA. G. Sacituzumab Govitecan>

---

USA. G. Sacituzumab Govitecan>'s subsections
(*) USA Approval Date: 2023. 02.03
>hziy
Company
RTM
RTM Web-Site
USA Patent Numbers

USA. G. Sacituzumab Govitecan>'s products
This section has no products